仅于乳腺断层合成摄影检出的结构扭曲与二维乳腺X线摄影检出者的结局比较
本回顾性研究纳入2009至2016年最终归为BI-RADS 4或5类的结构扭曲病例,比较仅DBT检出与2D乳腺X线检出者的恶性率及超声相关性。共181个病灶,2D可见122个(67.4%),仅DBT检出59个(32.6%);2D检出者恶性率43.4%(53/122)显著高于DBT检出者10.2%(6/59)(P < .001)。DBT检出可疑结构扭曲恶性率较低,但仍足以 warrant 活检。
要点
- 仅DBT检出的可疑结构扭曲恶性率为10.2%(6/59),2D检出者为43.4%(53/122)(P < .001)。
- 2D检出结构扭曲伴超声相关性的比例84.4%(103/122)高于DBT检出者的55.9%(33/59)(P < .001)。
- DBT检出结构扭曲有无超声相关性时恶性率无差异:有相关性12.1%(4/33),无相关性7.7%(2/26)。
核心结论
- 仅DBT检出的可疑结构扭曲恶性率低于2D乳腺X线摄影检出的可疑结构扭曲(10.2% vs 43.4%),但仍高至足以 warrant 活检。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并符合HIPAA;2009至2016年所有连续最终归为BI-RADS 4或5类的结构扭曲病例,由三名阅片者评估可见性(2D vs DBT);共纳入181个结构扭曲病灶。
关键影像表现/征象
- 181个结构扭曲病灶中,2D可见122个(67.4%),仅DBT检出59个(32.6%)。
- 在同时接受2D乳腺X线摄影和DBT的117名女性共121个结构扭曲病灶中,59个(48.8%)仅经DBT检出。
- 42名女性(43个病灶)在启用DBT前接受了2D乳腺X线摄影。
- 2D检出结构扭曲伴超声相关性的频率为84.4%(103/122),高于DBT检出者的55.9%(33/59)(P < .001)。
诊断标准与关键数值
- 最终病理恶性率:2D检出结构扭曲为43.4%(53/122),DBT检出结构扭曲为10.2%(6/59)(P < .001)。
- DBT检出结构扭曲伴超声相关性者恶性率为12.1%(4/33;95%CI:3.4%,28.2%),不伴超声相关性者为7.7%(2/26;95%CI:0.9%,25.1%)。
- 基于放射科医生怀疑程度的阴性预测值范围为91.8%-98.0%,但不足以放弃活检。
临床应用与阅片要点
- 仅DBT检出的可疑结构扭曲恶性率较低,但仍高至足以 warrant 活检。
- DBT检出结构扭曲有无超声相关性时恶性率无差异(12.1% vs 7.7%),未达统计学显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To compare the outcome of architectural distortion (AD) without associated mass only on digital breast tomosynthesis (DBT) with AD seen at two-dimensional (2D) mammography and to evaluate if the incidence of malignancy is influenced by the presence of a correlate at ultrasonography (US). Materials and Methods This retrospective study had institutional review board approval and was HIPAA compliant. All consecutive cases in which patients with AD were ultimately assigned Breast Imaging Reporting and Data System (BI-RADS) 4 or 5 categories from 2009 to 2016 were reviewed by three readers for visibility (2D vs DBT). The level of suspicion was assigned using a Likert scale. Pathologic results were compared between 2D-detected and DBT-detected AD. Frequencies were compared by using the McNemar and Pearson χ2 exact tests. Results One hundred eighty-one AD lesions were included; 122 (67.4%) were 2D visible while 59 (32.6%) were DBT detected. Forty-two women (with 43 lesions) underwent 2D mammography prior to initiation of DBT. In 117 women with 121 AD lesions who underwent 2D mammography plus DBT, 59 lesions (48.8%) were detected only with DBT. The malignancy rate based on final pathology was significantly higher for 2D-detected AD (53 [43.4%] of 122) compared with DBT (six [10.2%] of 59) (P < .001). A US correlate was more frequent with 2D-detected AD (103 [84.4%] of 122) than DBT (33 [55.9%] of 59) (P < .001). Malignancy rate was not different for DBT-detected AD with (four [12.1%] of 33; 95% confidence interval [CI]: 3.4%, 28.2%]) or without (two [7.7%] of 26; 95% CI: 0.9%, 25.1%]) a US correlate. NPV based on radiologists' level of suspicion was high (91.8%-98.0%) but not sufficient enough to forgo biopsy. Conclusion DBT-detected suspicious AD has a lower malignancy outcome compared with 2D mammography-detected suspicious AD, although still high enough to warrant biopsy. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Alshafeiy TI, Nguyen JV, Rochman CM, et al. Outcome of Architectural Distortion Detected Only at Breast Tomosynthesis versus 2D Mammography. Radiology. 2018. PMID: 29584593. doi:10.1148/radiol.2018171159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。